Mayo Clinic Preparing To Commence Phase II FDA Clinical Trial For The Treatment Of COVID-19 With Vicromax™

Press/Media: Expert Comment

PeriodApr 16 2020

Media coverage

15

Media coverage

Keywords

  • COVID-19